BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19608737)

  • 1. Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway.
    Ardi VC; Van den Steen PE; Opdenakker G; Schweighofer B; Deryugina EI; Quigley JP
    J Biol Chem; 2009 Sep; 284(38):25854-66. PubMed ID: 19608737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis.
    Ardi VC; Kupriyanova TA; Deryugina EI; Quigley JP
    Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20262-7. PubMed ID: 18077379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9.
    Zajac E; Schweighofer B; Kupriyanova TA; Juncker-Jensen A; Minder P; Quigley JP; Deryugina EI
    Blood; 2013 Dec; 122(25):4054-67. PubMed ID: 24174628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment.
    Deryugina EI; Zajac E; Juncker-Jensen A; Kupriyanova TA; Welter L; Quigley JP
    Neoplasia; 2014 Oct; 16(10):771-88. PubMed ID: 25379015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation.
    Bekes EM; Schweighofer B; Kupriyanova TA; Zajac E; Ardi VC; Quigley JP; Deryugina EI
    Am J Pathol; 2011 Sep; 179(3):1455-70. PubMed ID: 21741942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIMP-1 binding to proMMP-9/CD44 complex localized at the cell surface promotes erythroid cell survival.
    Lambert E; Bridoux L; Devy J; Dassé E; Sowa ML; Duca L; Hornebeck W; Martiny L; Petitfrère-Charpentier E
    Int J Biochem Cell Biol; 2009 May; 41(5):1102-15. PubMed ID: 19010442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagenolysis-dependent angiogenesis mediated by matrix metalloproteinase-13 (collagenase-3).
    Zijlstra A; Aimes RT; Zhu D; Regazzoni K; Kupriyanova T; Seandel M; Deryugina EI; Quigley JP
    J Biol Chem; 2004 Jun; 279(26):27633-45. PubMed ID: 15066996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel 82 kDa proMMP-9 species associated with the surface of leukaemic cells: (auto-)catalytic activation and resistance to inhibition by TIMP-1.
    Ries C; Pitsch T; Mentele R; Zahler S; Egea V; Nagase H; Jochum M
    Biochem J; 2007 Aug; 405(3):547-58. PubMed ID: 17489740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1.
    Vandooren J; Born B; Solomonov I; Zajac E; Saldova R; Senske M; Ugarte-Berzal E; Martens E; Van den Steen PE; Van Damme J; Garcia-Pardo A; Froeyen M; Deryugina EI; Quigley JP; Moestrup SK; Rudd PM; Sagi I; Opdenakker G
    Biochem J; 2015 Jan; 465(2):259-70. PubMed ID: 25360794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the hemopexin domain of matrix metalloproteinases in cell migration.
    Dufour A; Sampson NS; Zucker S; Cao J
    J Cell Physiol; 2008 Dec; 217(3):643-51. PubMed ID: 18636552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of MMP-9 by membrane type-1 MMP/MMP-2 axis stimulates tumor metastasis.
    Li Z; Takino T; Endo Y; Sato H
    Cancer Sci; 2017 Mar; 108(3):347-353. PubMed ID: 27987367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo.
    Kunimasa K; Ikekita M; Sato M; Ohta T; Yamori Y; Ikeda M; Kuranuki S; Oikawa T
    Cancer Sci; 2010 Nov; 101(11):2462-9. PubMed ID: 20670297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix.
    Collen A; Hanemaaijer R; Lupu F; Quax PH; van Lent N; Grimbergen J; Peters E; Koolwijk P; van Hinsbergh VW
    Blood; 2003 Mar; 101(5):1810-7. PubMed ID: 12393408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen.
    Seandel M; Noack-Kunnmann K; Zhu D; Aimes RT; Quigley JP
    Blood; 2001 Apr; 97(8):2323-32. PubMed ID: 11290594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifibrotic response of cardiac fibroblasts in hypertensive hearts through enhanced TIMP-1 expression by basic fibroblast growth factor.
    Kinoshita T; Ishikawa Y; Arita M; Akishima-Fukasawa Y; Fujita K; Inomata N; Suzuki T; Namiki A; Mikami T; Ikeda T; Yamazaki J; Ishii T; Akasaka Y
    Cardiovasc Pathol; 2014; 23(2):92-100. PubMed ID: 24322055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide from the C-terminal domain of tissue inhibitor of matrix metalloproteinases-2 (TIMP-2) inhibits membrane activation of matrix metalloproteinase-2 (MMP-2).
    Xu X; Mikhailova M; Chen Z; Pal S; Robichaud TK; Lafer EM; Baber S; Steffensen B
    Matrix Biol; 2011 Sep; 30(7-8):404-12. PubMed ID: 21839835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIMP-2 is required for efficient activation of proMMP-2 in vivo.
    Wang Z; Juttermann R; Soloway PD
    J Biol Chem; 2000 Aug; 275(34):26411-5. PubMed ID: 10827175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis.
    Lundin L; Larsson H; Kreuger J; Kanda S; Lindahl U; Salmivirta M; Claesson-Welsh L
    J Biol Chem; 2000 Aug; 275(32):24653-60. PubMed ID: 10816596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic regulation of angiogenesis and matrix degradation in bone regeneration--distraction osteogenesis compared to rigid fracture healing.
    Weiss S; Zimmermann G; Baumgart R; Kasten P; Bidlingmaier M; Henle P
    Bone; 2005 Dec; 37(6):781-90. PubMed ID: 16202678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.